litlas
Log inCreate account

Antonio Palumbo

Active 1983–2024

Also published as
Antônio Palumbo
182
Papers
59,300
Citations
117
h-index
178
i10-index

Citations

Citations per year for Antonio Palumbo1948: 1 citations1983: 1 citations1984: 8 citations1985: 17 citations1986: 42 citations1987: 22 citations1988: 27 citations1989: 18 citations1990: 16 citations1991: 14 citations1992: 11 citations1993: 14 citations1994: 10 citations1995: 9 citations1996: 3 citations1997: 6 citations1998: 5 citations1999: 11 citations2000: 12 citations2001: 16 citations2002: 19 citations2003: 20 citations2004: 21 citations2005: 29 citations2006: 34 citations2007: 63 citations2008: 84 citations2009: 228 citations2010: 229 citations2011: 399 citations2012: 311 citations2013: 424 citations2014: 490 citations2015: 468 citations2016: 632 citations2017: 713 citations2018: 580 citations2019: 2,305 citations2020: 2,352 citations2021: 2,055 citations2022: 1,335 citations2023: 828 citations2024: 1,328 citations2025: 487 citations2026: 26 citations1949–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,514 citing papers, 24.6% of this breakdownChina: 999 citing papers, 7% of this breakdownItaly: 978 citing papers, 6.8% of this breakdownGermany: 826 citing papers, 5.8% of this breakdownUnited Kingdom: 816 citing papers, 5.7% of this breakdownFrance: 753 citing papers, 5.3% of this breakdownSpain: 682 citing papers, 4.8% of this breakdownCanada: 489 citing papers, 3.4% of this breakdownNetherlands: 476 citing papers, 3.3% of this breakdownGreece: 397 citing papers, 2.8% of this breakdownAustralia: 380 citing papers, 2.7% of this breakdownBelgium: 293 citing papers, 2% of this breakdown
0%24.6%Other 25.8%

Institutions

Fields

  • Medicine73.3%
  • Biochemistry, Genetics and Molecular Biology20.3%
  • Immunology and Microbiology3.4%
  • Computer Science0.6%
  • Engineering0.4%
  • Chemistry0.3%
  • Other1.7%

Topics

  • Multiple Myeloma Research and Treatments19.4%
  • Protein Degradation and Inhibitors8.6%
  • Peptidase Inhibition and Analysis4.5%
  • Ubiquitin and proteasome pathways3.1%
  • Cancer Treatment and Pharmacology2.9%
  • CAR-T cell therapy research2.8%
  • Other58.7%

Coauthors

All papers

Open in search
  1. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Authors: Shaji Kumar, Bruno Paiva, Kenneth C. Anderson, Brian G.M. Durie, Ola Landgren, Philippe Moreau, Nikhil C. Munshi, Sagar Lonial, Joan Bladé, María‐Victoria Mateos, Meletios Α. Dimopoulos, Efstathios Kastritis, Mario Boccadoro, Robert Z. Orlowski, Hartmut Goldschmidt, Andrew Spencer, Jian Hou, Wee Joo Chng, Saad Z. Usmani, Elena Zamagni, Kazuyuki Shimizu, Sundar Jagannath, Hans Erik Johnsen, Evangelos Terpos, Tony Reiman, Robert A. Kyle, Pieter Sonneveld, Paul G. Richardson, Philip L. McCarthy, Heinz Ludwig, Wen-Ming Chen, Michèle Cavo, Jean‐Luc Harousseau, Suzanne Lentzsch, Jens Hillengaß, Antonio Palumbo, Alberto Órfão, S. Vincent Rajkumar, Jesús F. San Miguel, Hervé Avet‐Loiseau - The Lancet Oncology 2016 cited by 2,995

  2. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

    Authors: S. Vincent Rajkumar, Meletios Α. Dimopoulos, Antonio Palumbo, Joan Bladé, Giampaolo Merlini, María‐Victoria Mateos, Shaji Kumar, Jens Hillengaß, Efstathios Kastritis, Paul G. Richardson, Ola Landgren, Bruno Paiva, Angela Dispenzieri, Brendan M. Weiss, Xavier Leleu, Sonja Zweegman, Sagar Lonial, Laura Rosiñol, Elena Zamagni, Sundar Jagannath, Orhan Sezer, Sigurður Y. Kristinsson, Jo Caers, Saad Z. Usmani, Juan José Lahuerta, Hans Erik Johnsen, Meral Beksaç, Michèle Cavo, Hartmut Goldschmidt, Evangelos Terpos, Robert A. Kyle, Kenneth C. Anderson, Brian G.M. Durie, Jesús F. San Miguel - The Lancet Oncology 2014 cited by 4,869

  3. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    Authors: Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva, Henk M. Lokhorst, Hartmut Goldschmidt, Laura Rosiñol, Paul Richardson, S Caltagirone, Juan José Lahuerta, Thierry Façon, Sara Bringhen, Francesca Gay, Michel Attal, Roberto Passera, Andrew Spencer, Massimo Offidani, Shaji Kumar, Pellegrino Musto, Sagar Lonial, Maria Teresa Petrucci, Robert Z. Orlowski, Elena Zamagni, Gareth J. Morgan, Meletios Α. Dimopoulos, Brian G.M. Durie, Kenneth C. Anderson, Pieter Sonneveld, Jesús F. San Miguel, Michèle Cavo, S. Vincent Rajkumar, Philippe Moreau - Journal of Clinical Oncology 2015 cited by 2,178

  4. Multiple Myeloma

    Authors: Antonio Palumbo, Kenneth C. Anderson - New England Journal of Medicine 2011 cited by 2,324

  5. Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

    Authors: Antonio Palumbo, Asher Chanan‐Khan, Katja Weisel, Ajay K. Nooka, Tamás Masszi, Meral Beksaç, Ivan Špıčka, Vânia Hungria, Markus Munder, María‐Victoria Mateos, Tomer M. Mark, Ming Qi, Jordan M. Schecter, Himal Amin, Xiang Qin, William Deraedt, Tahamtan Ahmadi, Andrew Spencer, Pieter Sonneveld - New England Journal of Medicine 2016 cited by 1,513

  6. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    Authors: S. Vincent Rajkumar, Jean‐Luc Harousseau, Brian G.M. Durie, Kenneth C. Anderson, Meletios Α. Dimopoulos, Robert A. Kyle, Joan Bladé, Paul G. Richardson, Robert Z. Orlowski, David S. Siegel, Sundar Jagannath, Thierry Façon, Hervé Avet‐Loiseau, Sagar Lonial, Antonio Palumbo, Jeffrey A. Zonder, Heinz Ludwig, David H. Vesole, Orhan Sezer, Nikhil C. Munshi, Jesús F. San Miguel, on behalf of the International Myeloma Workshop Consensus Panel 1 - Blood 2011 cited by 1,034

  7. Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

    Authors: Sagar Lonial, Meletios Α. Dimopoulos, Antonio Palumbo, Darrell White, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Philippe Moreau, María‐Victoria Mateos, Hila Magen, Andrew R. Belch, Donna Reece, Meral Beksaç, Andrew Spencer, Heather Oakervee, Robert Z. Orlowski, Masafumi Taniwaki, Christoph Röllig, Hermann Einsele, Ka Lung Wu, Anil Singhal, Jesús F. San Miguel, Morio Matsumoto, Jessica Katz, Eric Bleickardt, Valerie Poulart, Kenneth C. Anderson, Paul G. Richardson - New England Journal of Medicine 2015 cited by 1,320

  8. Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

    Authors: Philippe Moreau, Tamás Masszi, Norbert Grząśko, Nizar J. Bahlis, Markus Hansson, Luděk Pour, Irwindeep Sandhu, Peter Ganly, Bartrum W. Baker, Sharon Jackson, Anne-Marie Stoppa, David R. Simpson, Peter Gimsing, Antonio Palumbo, Laurent Garderet, Michèle Cavo, Shaji Kumar, Cyrille Touzeau, Francis K. Buadi, Jacob P. Laubach, Deborah Berg, Jianchang Lin, Alessandra Di Bacco, Ai-Min Hui, Helgi van de Velde, Paul G. Richardson - New England Journal of Medicine 2016 cited by 1,054

  9. Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

    Authors: Pieter Sonneveld, Hervé Avet‐Loiseau, Sagar Lonial, Saad Z. Usmani, David S. Siegel, Kenneth C. Anderson, Wee Joo Chng, Philippe Moreau, Michel Attal, Robert A. Kyle, Jo Caers, Jens Hillengaß, Jesús F. San Miguel, Niels W.C.J. van de Donk, Hermann Einsele, Joan Bladé, Brian G.M. Durie, Hartmut Goldschmidt, María‐Victoria Mateos, Antonio Palumbo, Robert Z. Orlowski - Blood 2016 cited by 929

  10. Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

    Authors: Henk M. Lokhorst, Torben Plesner, Jacob P. Laubach, Hareth Nahi, Peter Gimsing, Markus Hansson, Monique C. Minnema, Ulrik Lassen, Jakub Krejcik, Antonio Palumbo, Niels W.C.J. van de Donk, Tahamtan Ahmadi, Imran Khan, Clarissa Uhlar, Jianping Wang, A. Kate Sasser, Nedjad Losic, Steen Lisby, Linda Basse, Nikolai C. Brun, Paul G. Richardson - New England Journal of Medicine 2015 cited by 1,116

  11. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

    Authors: Robert A. Kyle, Brian G.M. Durie, S. Vincent Rajkumar, Ola Landgren, Joan Bladé, Giampaolo Merlini, Nicolaus Kröger, Hermann Einsele, David H. Vesole, Meletios Α. Dimopoulos, Jesús F. San Miguel, Hervé Avet‐Loiseau, Roman Hájek, W M Chen, Kenneth C. Anderson, Heinz Ludwig, Pieter Sonneveld, S Pavlovsky, Antonio Palumbo, Paul G. Richardson, Bart Barlogie, Patricia T. Greipp, Robert Vescio, Ingemar Turesson, Jan Westin, Mario Boccadoro, on behalf of the International Myeloma Working Group - Leukemia 2010 cited by 876

  12. Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

    Authors: A. Keith Stewart, S. Vincent Rajkumar, Meletios Α. Dimopoulos, Tamás Masszi, Ivan Špıčka, Albert Oriol, Roman Hájek, Laura Rosiñol, David S. Siegel, Georgi Mihaylov, Vesselina Goranova‐Marinova, Péter Rajnics, Aleksandr Suvorov, Rubén Niesvizky, Andrzej Jakubowiak, Jesús F. San Miguel, Heinz Ludwig, Michael Wang, Vladimír Maisnar, Jiří Minařík, William Bensinger, María-Victoria Mateos, Dina Ben‐Yehuda, Vishal Kukreti, Naseem J. Zojwalla, Margaret Tonda, Xinqun Yang, Biao Xing, Philippe Moreau, Antonio Palumbo - New England Journal of Medicine 2014 cited by 1,324

  13. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

    Authors: Antonio Palumbo, Sara Bringhen, María‐Victoria Mateos, Alessandra Larocca, Thierry Façon, Shaji Kumar, Massimo Offidani, Philip L. McCarthy, Andrea Evangelista, Sagar Lonial, Sonja Zweegman, Pellegrino Musto, Evangelos Terpos, Andrew Belch, Roman Hájek, Heinz Ludwig, A. Keith Stewart, Philippe Moreau, Kenneth C. Anderson, Hermann Einsele, Brian G.M. Durie, Meletios Α. Dimopoulos, Ola Landgren, Jesús F. San Miguel, Paul G. Richardson, Pieter Sonneveld, S. Vincent Rajkumar - Blood 2015 cited by 762

  14. Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

    Authors: María‐Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold, Albert Oriol, David Simpson, Anupkumar George, Hartmut Goldschmidt, Alessandra Larocca, Asher Chanan‐Khan, Daniel W. Sherbenou, Irit Avivi, Noam Benyamini, Shinsuke Iida, Morio Matsumoto, Kenshi Suzuki, Vincent Ribrag, Saad Z. Usmani, Sundar Jagannath, Enrique M. Ocio, Paula Rodríguez‐Otero, Jesús F. San Miguel, Uma Kher, Mohammed Z.H. Farooqui, Jason J. Z. Liao, Patricia Marinello, Sagar Lonial, Andrew J. Nicol, George Grigoriadis, John Catalano, Richard LeBlanc, Mohamed Elemary, Nizar J. Bahlis, Thierry Façon, Lionel Karlin, Vincent Ribrag, Michel Attal, Hartmut Goldschmidt, Monika Engelhardt, Katja Weisel, Andréas Mackensen, Arnon Nagler, Dina Ben Yehuda, Irit Avivi, Noam Benyamini, Hila Magen‐Nativ, Antonio Palumbo, Michèle Cavo, Kensei Tobinai, Shinsuke Iida, Takaai Chou, Kenshi Suzuki, Hiroshi Kosugi, Masafumi Taniwaki, Kazutaka Sunami, Morio Matsumoto, Kiyoshi Ando, Peter Ganly, Hilary Blacklock, David Simpson, Anupkumar George, Fredrik Schjesvold, Bjørn Tore Gjertsen, Juan José Lahuerta, Joan Bladé, Albert Oriol Rocafiguera, María‐Victoria Mateos, Paula Rodríguez‐Otero, Sarah M. Larson, Djordje Atanackovic, Srinivas Devarakonda, Jacob D. Bitran, Jeffrey A. Zonder, Neil Morganstein, Mohammad Hay, Asher Chanan‐Khan, Gene Saylors, Ebenezer A. Kio, Ira Oliff, Dean Kirkel, Mikhail Shtivelband, Carrie Yuen, Andrew J. Yee, Jatin J. Shah, Myo Htut, Shahzad Raza, Saurabh Chhabra, Patrick J. Stiff, Parameswaran Hari, Bruce Bank, Ehsan Malek, Cristina Gasparetto, Ycaoub Faroun, Daniel W. Sherbenou, William Kreisle, Seema Singhal, Jacalyn Rosenblatt, Saad Z. Usmani, Wes Lee, Hana Safah, Jose Lutzky and 21 more - The Lancet Haematology 2019 cited by 253

  15. Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

    Authors: Philip L. McCarthy, Sarah A. Holstein, Maria Teresa Petrucci, Paul G. Richardson, Cyrille Hulin, Patrizia Tosi, Sara Bringhen, Pellegrino Musto, Kenneth C. Anderson, D. Caillot, Francesca Gay, Philippe Moreau, Gérald Marit, Sin‐Ho Jung, Zhinuan Yu, Benjamin Winograd, Robert Knight, Antonio Palumbo, Michel Attal - Journal of Clinical Oncology 2017 cited by 679

  16. Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting

    Authors: Paul G. Richardson, Jesús F. San Miguel, Philippe Moreau, Roman Hájek, Meletios Α. Dimopoulos, Jacob P. Laubach, Antonio Palumbo, Katarina Luptakova, Dorothy Romanus, Tomáš Skácel, Shaji Kumar, Kenneth C. Anderson - Blood Cancer Journal 2018 cited by 226

  17. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

    Authors: Sandy Amorim, Anastasios Stathis, Mary Gleeson, Sunil Iyengar, Valeria Magarotto, Xavier Leleu, Franck Morschhauser, Lionel Karlin, Florence Broussais, Keyvan Rezaï, Patrice Herait, Carmen Kahatt, François Lokiec, Gilles Salles, Thierry Façon, Antonio Palumbo, David Cunningham, Emanuele Zucca, Catherine Thiéblemont - The Lancet Haematology 2016 cited by 428

  18. Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

    Authors: Jesús F. San Miguel, Katja Weisel, Philippe Moreau, Martha Q. Lacy, Kevin Song, Michel Delforge, Lionel Karlin, Hartmut Goldschmidt, Anne Banos, Albert Oriol, Adrían Alegre, Christine Chen, Michèle Cavo, Laurent Garderet, Valentina Ivanova, Joaquín Martínez‐López, Andrew R. Belch, Antonio Palumbo, Stephen Schey, Pieter Sonneveld, Xin Yu, Lars Sternås, Christian Jacques, Mohamed H. Zaki, Meletios Α. Dimopoulos - The Lancet Oncology 2013 cited by 799

  19. IMWG consensus on risk stratification in multiple myeloma

    Authors: Wee Joo Chng, Angela Dispenzieri, C-S Chim, Rafaël Fonseca, Hartmut Goldschmidt, Suzanne Lentzsch, Nikhil C. Munshi, Antonio Palumbo, Jesús F. San Miguel, Pieter Sonneveld, Michèle Cavo, Saad Z. Usmani, Brian G.M. Durie, Hervé Avet‐Loiseau, on behalf of the International Myeloma Working Group - Leukemia 2013 cited by 598

  20. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

    Authors: Meletios Α. Dimopoulos, Philippe Moreau, Antonio Palumbo, Douglas Joshua, Luděk Pour, Roman Hájek, Thierry Façon, Heinz Ludwig, Albert Oriol, Hartmut Goldschmidt, Laura Rosiñol, Jan Štraub, Aleksandr Suvorov, Carla Araujo, Elena Rimashevskaya, Tomáš Pika, Gianluca Gaïdano, Katja Weisel, Vesselina Goranova‐Marinova, Anthony P. Schwarer, Leonard Minuk, Tamás Masszi, Ievgenii Karamanesht, Massimo Offidani, Vânia Hungria, Andrew Spencer, Robert Z. Orlowski, Heidi H. Gillenwater, Nehal Mohamed, Shibao Feng, Wee Joo Chng - The Lancet Oncology 2015 cited by 849

  21. Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

    Authors: Antonio Palumbo, Federica Cavallo, Francesca Gay, Francesco Di Raimondo, Dina Ben Yehuda, Maria Teresa Petrucci, Sara Pezzatti, Tommaso Caravita, Chiara Cerrato, Elena Ribakovsky, Mariella Genuardi, Anna Maria Cafro, Magda Marcatti, Lucio Catalano, Massimo Offidani, Angelo Michele Carella, Elena Zamagni, Francesca Patriarca, Pellegrino Musto, Andrea Evangelista, Giovannino Ciccone, Paola Omedè, Claudia Crippa, Paolo Corradini, Arnon Nagler, Mario Boccadoro, Michèle Cavo - New England Journal of Medicine 2014 cited by 781

  22. International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment

    Authors: Meletios Α. Dimopoulos, Pieter Sonneveld, Nelson Leung, Giampaolo Merlini, Heinz Ludwig, Efstathios Kastritis, Hartmut Goldschmidt, Douglas Joshua, Robert Z. Orlowski, Raymond Powles, David H. Vesole, Laurent Garderet, Hermann Einsele, Antonio Palumbo, Michèle Cavo, Paul G. Richardson, Philippe Moreau, Jesús F. San Miguel, S. Vincent Rajkumar, Brian G.M. Durie, Evangelos Terpos - Journal of Clinical Oncology 2016 cited by 419

  23. European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications

    Authors: Evangelos Terpos, Martina Kleber, Monika Engelhardt, Sonja Zweegman, Francesca Gay, Efstathios Kastritis, Niels W.C.J. van de Donk, Benedetto Bruno, Orhan Sezer, Annemiek Broijl, Sara Bringhen, Meral Beksaç, Alessandra Larocca, Roman Hájek, Pellegrino Musto, Hans Erik Johnsen, Fortunato Morabito, Heinz Ludwig, Michèle Cavo, H. Einsele, Pieter Sonneveld, Meletios Α. Dimopoulos, Antonio Palumbo, on behalf of the European Myeloma Network - Haematologica 2015 cited by 398

  24. Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life

    Authors: Evangelos Terpos, Joseph Mıkhael, Roman Hájek, Ajai Chari, Sonja Zweegman, Hans C. Lee, María‐Victoria Mateos, Alessandra Larocca, Karthik Ramasamy, Martin Kaiser, Gordon Cook, Katja Weisel, Caitlin Costello, Jennifer Elliott, Antonio Palumbo, Saad Z. Usmani - Blood Cancer Journal 2021 cited by 114